New technology detects blood clots with simple in-home test

13-May-2016 - But researchers at the University of Cincinnati -- supported by the National Science Foundation -- are developing materials and technology for a simple in-home screening that could be a game changer for patients with several life-threatening conditions. Patients with cardiovascular disease, ...

Guideline: Blood thinners to prevent stroke

26-Feb-2014 - An updated guideline from the American Academy of Neurology recommends that people with nonvalvular atrial fibrillation, or irregular heartbeat, take oral anticoagulants, a type of blood thinner pill, to prevent stroke. The guideline is published in Neurology®. The World Stroke Organization has ...

Combating cancer's double whammy

New research to fight life-threatening blood clots in cancer patients

16-Nov-2010 - A major study is under way at The University of Nottingham which could lead to better prevention of a serious and sometimes fatal complication in cancer patients. Venous thromboembolism (VTE or ‘blood clotting’) is one of the most common causes of death in the UK and 20 per cent of these deaths ...

London Genetics expands its senior advisory team

23-Jul-2010 - London Genetics Limited announced that it has augmented the strength of its team with the appointment of two senior advisers, Professors Stephen DeCherney and Munir Pirmohamed. Stephen DeCherney MD, MPH, is Professor of Medicine at the University of Carolina, and was previously President, Global ...

Adding genetics to a patient's clinical profile might lead to more accurate blood-thinner dosing

23-Feb-2009 - Including genetic information in a patient's clinical profile might help determine the optimal starting dose of the common blood-thinner warfarin, according to findings from a large-scale study that will be published in the New England Journal of Medicine. Researchers from more than 20 ...

Virtual trials could improve drug development

19-Dec-2007 - New techniques for creating virtual early-stage clinical trials using advanced modelling techniques will improve the process of drug development, according to Dr Amin Rostami, from the University of Sheffield and Director of Research & Development at Simcyp. Speaking at the British ...

Osmetech licenses VKOR pharmacogenetic marker for warfarin dosage management from University of Washington

13-Mar-2007 - Osmetech plc announced that it has taken a worldwide non-exclusive license from the University of Washington (UW) to Vitamin K Epoxide Reductase (VKOR) gene polymorphisms. This gene is a key diagnostic marker for the management of warfarin dosage. Financial details are not disclosed. This ...

Bayer and Ortho-McNeil, Inc. Outline Phase III Study Program of Oral Factor Xa Inhibitor Rivaroxaban in Chronic Indications

Patient Recruitment for Phase III Clinical Trial to Start in Studies of Oral Anticoagulant in Chronic Indications

10-Nov-2006 - After extensive discussions with the regulatory authorities in the U.S. and Europe, Bayer and Ortho-McNeil, Inc. have determined the final design of the phase III study program for the oral anticoagulant rivaroxaban in two chronic indications: Stroke prevention in atrial fibrillation (SPAF) and ...

Basilea Presents Compelling Clinical and Preclinical Data on its Novel Broad-spectrum Antifungal BAL8557

28-Jun-2006 - Basilea Pharmaceutica Ltd. presented data on its antifungal BAL8557 showing a promising safety and drug-drug interaction profile. Additional data confirms broad-spectrum antifungal activity. Basilea presented clinical posters demonstrating a favorable drug-drug interaction profile for BAL8557 and ...

University Awarded GBP 2 Million To Study Role Of Genetics In Drug Efficacy

25-Jun-2004 - Liverpool. The University of Liverpool has been awarded GBP 2 million in funding by the Department of Health to study how a patient's genetic make-up can affect their responses to certain drugs. The funding will be shared between three projects in an effort to advance knowledge of ...